70 related articles for article (PubMed ID: 22552889)
21. L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1.
Cheng L; Wu Q; Huang Z; Guryanova OA; Huang Q; Shou W; Rich JN; Bao S
EMBO J; 2011 Mar; 30(5):800-13. PubMed ID: 21297581
[TBL] [Abstract][Full Text] [Related]
22. DNA-PKcs deficiency inhibits glioblastoma cell-derived angiogenesis after ionizing radiation.
Liu Y; Zhang L; Liu Y; Sun C; Zhang H; Miao G; Di CX; Zhou X; Zhou R; Wang Z
J Cell Physiol; 2015 May; 230(5):1094-103. PubMed ID: 25294801
[TBL] [Abstract][Full Text] [Related]
23. Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.
Cui Y; Palii SS; Innes CL; Paules RS
Cell Cycle; 2014; 13(22):3541-50. PubMed ID: 25483091
[TBL] [Abstract][Full Text] [Related]
24. MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells.
Badiga AV; Chetty C; Kesanakurti D; Are D; Gujrati M; Klopfenstein JD; Dinh DH; Rao JS
PLoS One; 2011; 6(6):e20614. PubMed ID: 21698233
[TBL] [Abstract][Full Text] [Related]
25. CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors.
Anderson VE; Walton MI; Eve PD; Boxall KJ; Antoni L; Caldwell JJ; Aherne W; Pearl LH; Oliver AW; Collins I; Garrett MD
Cancer Res; 2011 Jan; 71(2):463-72. PubMed ID: 21239475
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic options for recurrent malignant glioma.
Niyazi M; Siefert A; Schwarz SB; Ganswindt U; Kreth FW; Tonn JC; Belka C
Radiother Oncol; 2011 Jan; 98(1):1-14. PubMed ID: 21159396
[TBL] [Abstract][Full Text] [Related]
27. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain.
Marcu LG
Cancer Treat Rev; 2010 Dec; 36(8):606-14. PubMed ID: 20494524
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.
Godlewski J; Nowicki MO; Bronisz A; Nuovo G; Palatini J; De Lay M; Van Brocklyn J; Ostrowski MC; Chiocca EA; Lawler SE
Mol Cell; 2010 Mar; 37(5):620-32. PubMed ID: 20227367
[TBL] [Abstract][Full Text] [Related]
29. MDC1: The art of keeping things in focus.
Jungmichel S; Stucki M
Chromosoma; 2010 Aug; 119(4):337-49. PubMed ID: 20224865
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells.
Zhong Z; Yeow WS; Zou C; Wassell R; Wang C; Pestell RG; Quong JN; Quong AA
Cancer Res; 2010 Mar; 70(5):2105-14. PubMed ID: 20179208
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair.
Bolderson E; Richard DJ; Zhou BB; Khanna KK
Clin Cancer Res; 2009 Oct; 15(20):6314-20. PubMed ID: 19808869
[TBL] [Abstract][Full Text] [Related]
32. Reduced proliferation and enhanced migration: two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1.
Evdokimova V; Tognon C; Ng T; Sorensen PH
Cell Cycle; 2009 Sep; 8(18):2901-6. PubMed ID: 19713745
[TBL] [Abstract][Full Text] [Related]
33. Keeping checkpoint kinases in line: new selective inhibitors in clinical trials.
Ashwell S; Janetka JW; Zabludoff S
Expert Opin Investig Drugs; 2008 Sep; 17(9):1331-40. PubMed ID: 18694366
[TBL] [Abstract][Full Text] [Related]
34. Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB.
Monferran S; Skuli N; Delmas C; Favre G; Bonnet J; Cohen-Jonathan-Moyal E; Toulas C
Int J Cancer; 2008 Jul; 123(2):357-364. PubMed ID: 18464290
[TBL] [Abstract][Full Text] [Related]
35. CDK inhibitors: cell cycle regulators and beyond.
Besson A; Dowdy SF; Roberts JM
Dev Cell; 2008 Feb; 14(2):159-69. PubMed ID: 18267085
[TBL] [Abstract][Full Text] [Related]
36. Unique requirement for Rb/E2F3 in neuronal migration: evidence for cell cycle-independent functions.
McClellan KA; Ruzhynsky VA; Douda DN; Vanderluit JL; Ferguson KL; Chen D; Bremner R; Park DS; Leone G; Slack RS
Mol Cell Biol; 2007 Jul; 27(13):4825-43. PubMed ID: 17452454
[TBL] [Abstract][Full Text] [Related]
37. Ionising radiation induces changes associated with epithelial-mesenchymal transdifferentiation and increased cell motility of A549 lung epithelial cells.
Jung JW; Hwang SY; Hwang JS; Oh ES; Park S; Han IO
Eur J Cancer; 2007 May; 43(7):1214-24. PubMed ID: 17379505
[TBL] [Abstract][Full Text] [Related]
38. Radiation-induced cell signaling: inside-out and outside-in.
Valerie K; Yacoub A; Hagan MP; Curiel DT; Fisher PB; Grant S; Dent P
Mol Cancer Ther; 2007 Mar; 6(3):789-801. PubMed ID: 17363476
[TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 induction of cellular migration requires p27(KIP1).
Li Z; Jiao X; Wang C; Ju X; Lu Y; Yuan L; Lisanti MP; Katiyar S; Pestell RG
Cancer Res; 2006 Oct; 66(20):9986-94. PubMed ID: 17047061
[TBL] [Abstract][Full Text] [Related]
40. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways.
Park CM; Park MJ; Kwak HJ; Lee HC; Kim MS; Lee SH; Park IC; Rhee CH; Hong SI
Cancer Res; 2006 Sep; 66(17):8511-9. PubMed ID: 16951163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
